8 studies found for:    Open Studies | "Dysentery"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Dysentery" (8 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea
Conditions: Acute Watery Diarrhea;   Dysentery/Febrile Diarrhea
Interventions: Drug: Single dose rifaximin 1650 mg;   Drug: Single dose azithromycin 500 mg;   Drug: Single dose levofloxacin 500 mg;   Drug: Single dose azithromycin 1000 mg plus loperamide;   Drug: Single dose azithromycin 1000 mg plus placebo
2 Not yet recruiting Auranofin Trial for GI Protozoa
Conditions: Giardiasis;   Amoebic Dysentery
Interventions: Drug: Auranofin;   Other: Placebo
3 Recruiting Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Intervention: Biological: Shigella flexneri 2a InvaplexAR
4 Not yet recruiting Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections
Condition: Dysentery
Intervention: Other: Laboratory Tests
5 Not yet recruiting A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Condition: Shigella Sonnei Infection
Interventions: Biological: S. sonnei vaccine 25 μg;   Biological: S. sonnei vaccine 100 μg;   Biological: Menveo;   Biological: Boostrix
6 Recruiting Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
Condition: Traveler's Diarrhea
Interventions: Drug: Rifamycin SV MMX;   Drug: Ciprofloxacin
7 Not yet recruiting Clinical Trial of CBS-2004 (Bimuno)® in Prevention of Travelers' Diarrhea
Condition: Traveler's Diarrhea
Interventions: Drug: Bimuno® (galacto-oligosaccharides);   Drug: Placebo
8 Not yet recruiting Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
Conditions: Travelers' Diarrhea;   Functional Bowel Disorders;   Reactive Arthritis
Interventions: Drug: Rifaximin;   Drug: Placebo

Indicates status has not been verified in more than two years